Increased cortical kynurenate content in schizophrenia

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans

John H. Krystal · Archives of General Psychiatry · 1994 · 3.3K citations

Medicine, Neuroscience, Pharmacology +13

Glutamate Receptor Dysfunction and Schizophrenia

John W. Olney · Archives of General Psychiatry · 1995 · 1.7K citations

Medicine, Neuroscience, Psychiatry +17

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate

Nabil A. Anis, Stephen C. Berry, N.R. Burton et al. · British Journal of Pharmacology · 1983 · 1.4K citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain

Robert Schwarcz, William O. Whetsell, Richard M. Mangano · Science · 1983 · 1.3K citations

Life Sciences, Neurobiology, Neuroscience +16

Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia

Adrienne C. Lahti · Neuropsychopharmacology · 1995 · 905 citations · Full text

Medicine, Pharmacology, Psychiatry +14